Tower Trust & Investment Company’s Bristol-Myers Squibb BMY Stock Holding History

Tower Trust & Investment Company’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$585K	Buy	10,147 +154	+2%	+$8.84K	0.35%	65
2026 Q1	$606K	Sell	9,993 -134	-1%	-$7.81K	0.4%	65
2025 Q4	$546K	Buy	10,127 +11	+0.1%	+$529	0.34%	72
2025 Q3	$456K	Sell	10,116 -26	-0.3%	-$1.21K	0.31%	71
2025 Q2	$469K	Buy	10,142 +270	+3%	+$13.3K	0.33%	73
2025 Q1	$496K	Buy	+9,872	New	+$575K	0.4%	68

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Tower Trust & Investment Company's BMY Position: Q2 2026 in Review

Tower Trust & Investment Company increased its Bristol-Myers Squibb (BMY) stake by 1.5% in Q2 2026, buying an estimated $8.84K and bringing the position to 10,147 shares worth $585K. The position accounts for 0.35% of the portfolio, ranked #65.

Tower Trust & Investment Company first reported a position in BMY in Q1 2025 and has held it in 6 quarters since. The position peaked at $606K in Q1 2026. 1,031 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Tower Trust & Investment Company held 10,147 shares of Bristol-Myers Squibb worth $585K as of Q2 2026.
Tower Trust & Investment Company bought 154 Bristol-Myers Squibb shares in Q2 2026, an estimated $8.84K.
Bristol-Myers Squibb made up 0.35% of Tower Trust & Investment Company's portfolio in Q2 2026, its #65 holding.
Tower Trust & Investment Company first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 6 quarters since.
Tower Trust & Investment Company's Bristol-Myers Squibb position peaked at $606K in Q1 2026.
1,031 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Tower Trust & Investment Company's 13F filing for Q2 2026, filed 9 Jul 2026.